Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Rio2 Limited stock logo
ATM
Rio2
C$0.68
+1.5%
C$0.68
C$0.57
C$0.86
C$57.62MN/A114,654 shs15,000 shs
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
$3.58
+4.1%
$3.31
$1.92
$11.60
$188.90M2.42349,558 shs231,673 shs
POW
Powered Brands
$10.13
$10.09
$9.74
$10.13
$260.23MN/A21,543 shs667 shs
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Rio2 Limited stock logo
ATM
Rio2
0.00%0.00%0.00%0.00%0.00%
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
+4.07%-11.82%-12.90%-13.53%+16.61%
POW
Powered Brands
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Rio2 Limited stock logo
ATM
Rio2
N/AN/AN/AN/AN/AN/AN/AN/A
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
3.6691 of 5 stars
3.01.00.04.61.73.30.6
POW
Powered Brands
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Rio2 Limited stock logo
ATM
Rio2
0.00
N/AN/AN/A
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
2.00
Hold$9.00151.40% Upside
POW
Powered Brands
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest POW, KOD, AFRK, and ATM Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/31/2025
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$3.00 ➝ $3.00
(Data available from 5/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Rio2 Limited stock logo
ATM
Rio2
N/AN/AN/AN/AN/AN/A
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
N/AN/AN/AN/A$5.07 per shareN/A
POW
Powered Brands
N/AN/A$0.09 per share106.77($0.59) per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Rio2 Limited stock logo
ATM
Rio2
N/AN/A0.00N/AN/AN/AN/AN/A
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
-$260.49M-$3.63N/AN/AN/AN/A-84.52%-45.40%8/13/2025 (Estimated)
POW
Powered Brands
$2.85MN/A0.00N/AN/A-67.46%3.24%N/A

Latest POW, KOD, AFRK, and ATM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/14/2025Q1 2025
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
-$0.89-$1.09-$0.20-$1.09N/AN/A
3/27/2025Q4 2024
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
-$0.90-$0.84+$0.06-$0.84N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Rio2 Limited stock logo
ATM
Rio2
N/AN/AN/AN/AN/A
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
N/AN/AN/AN/AN/A
POW
Powered Brands
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Rio2 Limited stock logo
ATM
Rio2
N/AN/AN/A
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
N/A
8.42
8.42
POW
Powered Brands
N/A
0.47
0.47

Institutional Ownership

CompanyInstitutional Ownership
Rio2 Limited stock logo
ATM
Rio2
N/A
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
89.06%
POW
Powered Brands
98.49%

Insider Ownership

CompanyInsider Ownership
Rio2 Limited stock logo
ATM
Rio2
N/A
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
45.30%
POW
Powered Brands
19.77%
CompanyEmployeesShares OutstandingFree FloatOptionable
Rio2 Limited stock logo
ATM
Rio2
N/A84.74 millionN/ANot Optionable
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
9052.76 million28.79 millionOptionable
POW
Powered Brands
225.70 million20.62 millionNot Optionable

Recent News About These Companies

The checkout has left the website: What Google’s AI play means for Indian brands
InMobi launches AI-powered commerce platform
Do You Trust Influencer Beauty Brands?
Best Battery Platforms for Power Tools
AI-powered CX: Changing the way we connect
The Power of Brand Words in Business Success
Every EV From Every Brand in America
The Power of Personal Branding

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Rio2 stock logo

Rio2 CVE:ATM

C$0.68 +0.01 (+1.49%)
As of 07/26/2018

Atacama Pacific Gold Corporation, an exploration stage company, engages in the acquisition, exploration, and development of gold properties in Chile. The company principally holds a 100% interest in the Cerro Maricunga gold project located in Region III northeast of the city of Copiapo. Atacama Pacific Gold Corporation was incorporated in 2008 and is headquartered in Toronto, Canada.

Kodiak Sciences stock logo

Kodiak Sciences NASDAQ:KOD

$3.58 +0.14 (+4.07%)
Closing price 05/27/2025 04:00 PM Eastern
Extended Trading
$3.45 -0.13 (-3.63%)
As of 05/27/2025 06:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as Phase III clinical study for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy. The company's preclinical stage product candidate includes KSI-501, a bispecific conjugate to treat retinal diseases with an inflammatory component; and KSI-601, a triplet biopolymer conjugate for the treatment of dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.

Powered Brands NASDAQ:POW

Powered Brands does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Powered Brands was incorporated in 2020 and is based in New York, New York.